Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Novel antiinflammatory protein available for licensing

Jan. 22, 1997

AutoImmune updates clinical program for oral RA product

Jan. 17, 1997

Genelabs completes first pivotal trial on SLE Rx

Jan. 16, 1997

Chiroscience investigates MMP/TNF inhibitors

Jan. 16, 1997

Searle describes antiinflammatory oxazoles

Jan. 15, 1997

New COX-2 inhibitor series reported by Merck Frosst

Jan. 15, 1997

Chiroscience reports new peptidyl compounds for treating degenerative diseases

Jan. 14, 1997

Phase I ConXn data reported

Jan. 10, 1997

Chondrex license agreement option exercised

Jan. 10, 1997

Keoprofen generic approval

Jan. 9, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...